{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:11:41Z","timestamp":1782123101868,"version":"3.54.5"},"reference-count":44,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2024,2,1]]},"DOI":"10.3724\/abbs.2024022","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T06:39:47Z","timestamp":1708670387000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":2,"title":["AHR signaling pathway mediates mitochondrial oxidative                     phosphorylation which leads to cytarabine resistance"],"prefix":"10.3724","author":[{"given":"Yan","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyu","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2024,2,26]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"307","DOI":"10. 1146\/annurev. pa. 35. 040195. 001515","volume":"35","author":"Hankinson O","year":"1995","unstructured":"Hankinson O. The Aryl hydrocarbon receptor complex. Annu                             Rev Pharmacol Toxicol, 1995, 35: 307-340.","journal-title":"Annu                             Rev Pharmacol Toxicol"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.3390\/cimb45050248","volume":"45","author":"Grishanova AY","year":"2023","unstructured":"Grishanova AY, Klyushova LS, Perepechaeva ML. AhR and Wnt\/\u03b2-catenin signaling pathways and their interplay. Curr Issues Mol Biol, 2023, 45: 3848-3876.","journal-title":"Curr Issues Mol Biol"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbcan.2013.05.001","volume":"1836","author":"Feng S","year":"2013","unstructured":"Feng S, Cao Z, Wang X. Role of aryl hydrocarbon receptor in cancer. Biochim                             Biophys Acta Rev Cancer, 2013, 1836: 197-210.","journal-title":"Biochim                             Biophys Acta Rev Cancer"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"801","DOI":"10. 1038\/nrc3846","volume":"14","author":"Murray IA","year":"2014","unstructured":"Murray IA, Patterson AD, Perdew GH. Aryl hydrocarbon receptor ligands in cancer: friend and foe. Nat Rev Cancer, 2014, 14: 801-814.","journal-title":"Nat Rev Cancer"},{"key":"CITATION5","doi-asserted-by":"crossref","unstructured":"Nishimura T, Andoh A, Inatomi O, Shioya M, Yagi Y, Tsujikawa T,                         Fujiyama Y. Amphiregulin and epiregulin expression in neoplastic and                         inflammatory lesions in the colon.                              Oncol Rep                                                  2008, 19: 105\u2013110.","DOI":"10.3892\/or.19.1.105"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.semcdb.2014.03.005","volume":"28","author":"Riese DJ","year":"2014","unstructured":"Riese DJ, Cullum RL. Epiregulin: roles in normal physiology and cancer. Semin Cell                             Dev Biol, 2014, 28: 49-56.","journal-title":"Semin Cell                             Dev Biol"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"11786469231185102","DOI":"10. 1177\/11786469231185102","volume":"16","author":"Shadboorestan A","year":"2023","unstructured":"Shadboorestan A, Koual M, Dairou J, Coumoul X. The role of the kynurenine\/AhR pathway in diseases related to                         metabolism and cancer. Int J                             Tryptophan Res, 2023, 16:","journal-title":"Int J                             Tryptophan Res"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"5644","DOI":"10.1038\/s41467-022-33285-x","volume":"13","author":"Shi D","year":"2022","unstructured":"Shi D, Wu X, Jian Y, Wang J, Huang C, Mo S, Li Y. USP14 promotes tryptophan metabolism and immune suppression by                         stabilizing IDO1 in colorectal cancer. Nat Commun, 2022, 13:","journal-title":"Nat Commun"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature10491","volume":"478","author":"Opitz CA","year":"2011","unstructured":"Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, Schumacher T. An endogenous tumour-promoting ligand of the human aryl                         hydrocarbon receptor. Nature, 2011, 478: 197-203.","journal-title":"Nature"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.cell.2020.07.038","volume":"182","author":"Sadik A","year":"2020","unstructured":"Sadik A, Somarribas Patterson LF, \u00d6zt\u00fcrk S, Mohapatra SR, Panitz V, Secker PF, Pf\u00e4nder P. IL4I1 is a metabolic immune checkpoint that activates the AHR and                         promotes tumor progression. Cell, 2020, 182: 1252-1270.e34.","journal-title":"Cell"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"173921","DOI":"10.1016\/j.ejphar.2021.173921","volume":"896","author":"Ala M","year":"2021","unstructured":"Ala M. The footprint of kynurenine pathway in every cancer: a new target                         for chemotherapy. Eur J                             Pharmacol, 2021, 896:","journal-title":"Eur J                             Pharmacol"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.semcancer.2022.10.003","volume":"86","author":"Therachiyil L","year":"2022","unstructured":"Therachiyil L, Hussein OJ, Uddin S, Korashy HM. Regulation of the aryl hydrocarbon receptor in cancer and cancer                         stem cells of gynecological malignancies: An update on signaling pathways. Semin                             Cancer Biol, 2022, 86: 1186-1202.","journal-title":"Semin                             Cancer Biol"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3390\/ijms22010387","volume":"22","author":"Wang Z","year":"2021","unstructured":"Wang Z, Snyder M, Kenison JE, Yang K, Lara B, Lydell E, Bennani K. How the AHR became important in cancer: the role of chronically                         active AHR in cancer aggression. Int J Mol Sci, 2021, 22:","journal-title":"Int J Mol Sci"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"101530","DOI":"10. 1016\/j. redox. 2020. 101530","volume":"34","author":"Vogel CFA","year":"2020","unstructured":"Vogel CFA, Van Winkle LS, Esser C, Haarmann-Stemmann T. The aryl hydrocarbon receptor as a target of environmental                         stressors\u2014implications for pollution mediated stress and inflammatory                         responses. Redox Biol, 2020, 34:","journal-title":"Redox Biol"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"Warburg O","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science, 1956, 123: 309-314.","journal-title":"Science"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1158\/1078-0432.CCR-17-3070","volume":"24","author":"Ashton TM","year":"2018","unstructured":"Ashton TM, McKenna WG, Kunz-Schughart LA, Higgins GS. Oxidative phosphorylation as an emerging target in cancer therapy. Clin Cancer                             Res, 2018, 24: 2482-2490.","journal-title":"Clin Cancer                             Res"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/ijc.32616","volume":"146","author":"Sica V","year":"2020","unstructured":"Sica V, Bravo-San Pedro JM, Stoll G, Kroemer G. Oxidative phosphorylation as a potential therapeutic target for                         cancer therapy. Intl J Cancer, 2020, 146: 10-17.","journal-title":"Intl J Cancer"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"265","DOI":"10. 1038\/cr. 2017. 155","volume":"28","author":"Porporato PE","year":"2018","unstructured":"Porporato PE, Filigheddu N, Pedro JMBS, Kroemer G, Galluzzi L. Mitochondrial metabolism and cancer. Cell Res, 2018, 28: 265-280.","journal-title":"Cell Res"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.semcancer.2022.02.002","volume":"86","author":"Greene J","year":"2022","unstructured":"Greene J, Segaran A, Lord S. Targeting OXPHOS and the electron transport chain in cancer;                         Molecular and therapeutic implications. Semin                             Cancer Biol, 2022, 86: 851-859.","journal-title":"Semin                             Cancer Biol"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.cell.2020.07.039","volume":"182","author":"Bonnay F","year":"2020","unstructured":"Bonnay F, Veloso A, Steinmann V, K\u00f6cher T, Abdusselamoglu MD, Bajaj S, Rivelles E. Oxidative metabolism drives immortalization of neural stem cells                         during tumorigenesis. Cell, 2020, 182: 1490-1507.","journal-title":"Cell"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41586-019-0993-x","volume":"567","author":"Shi Y","year":"2019","unstructured":"Shi Y, Lim SK, Liang Q, Iyer SV, Wang HY, Wang Z, Xie X. Gboxin is an oxidative phosphorylation inhibitor that targets                         glioblastoma. Nature, 2019, 567: 341-346.","journal-title":"Nature"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"115531","DOI":"10. 1016\/j. bcp. 2023. 115531","volume":"211","author":"Cadassou O","year":"2023","unstructured":"Cadassou O, Jordheim LP. OXPHOS inhibitors, metabolism and targeted therapies in cancer. Biochem                             Pharmacol, 2023, 211:","journal-title":"Biochem                             Pharmacol"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","volume":"24","author":"Molina JR","year":"2018","unstructured":"Molina JR, Sun Y, Protopopova M, Gera S, Bandi M, Bristow C, McAfoos T. An inhibitor of oxidative phosphorylation exploits cancer                         vulnerability. Nat Med, 2018, 24: 1036-1046.","journal-title":"Nat Med"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.3390\/cells10081901","volume":"10","author":"Lee HY","year":"2021","unstructured":"Lee HY, Nga HT, Tian J, Yi HS. Mitochondrial metabolic signatures in hepatocellular carcinoma. Cells, 2021, 10:","journal-title":"Cells"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","volume":"7","author":"Farge T","year":"2017","unstructured":"Farge T, Saland E, de Toni F, Aroua N, Hosseini M, Perry R, Bosc C. Chemotherapy-resistant human acute myeloid leukemia cells are not                         enriched for leukemic stem cells but require oxidative metabolism. Cancer Discov, 2017, 7: 716-735.","journal-title":"Cancer Discov"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1080\/10245332.2017.1402454","volume":"23","author":"Yucel B","year":"2018","unstructured":"Yucel B, Sonmez M. Repression of oxidative phosphorylation sensitizes leukemia cell                         lines to cytarabine. Hematology, 2018, 23: 330-336.","journal-title":"Hematology"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/abbs\/gmab017","volume":"53","author":"Jia Y","year":"2021","unstructured":"Jia Y, Guo J, Zhao Y, Zhang Z, Shi L, Fang Y, Wu D. AHR signaling pathway reshapes the metabolism of AML\/MDS cells                         and potentially leads to cytarabine resistance. Acta Biochim Biophys                             Sin, 2021, 53: 492-500.","journal-title":"Acta Biochim Biophys                             Sin"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1093\/abbs\/gmab122","volume":"53","author":"Jia Y","year":"2021","unstructured":"Jia Y, Zhao Y, Zhang Z, Shi L, Fang Y, Chang C. Aryl hydrocarbon receptor signaling pathway plays important roles                         in the proliferative and metabolic properties of bone marrow mesenchymal                         stromal cells. Acta Biochim Biophys                             Sin, 2021, 53: 1428-1439.","journal-title":"Acta Biochim Biophys                             Sin"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.dib.2016.05.018","volume":"8","author":"Hwang HJ","year":"2016","unstructured":"Hwang HJ, Steidemann M, Dunivin TK, Rizzo M, LaPres JJ. Data of enzymatic activities of the electron transport chain and                         ATP synthase complexes in mouse hepatoma cells following exposure to                         2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Data Brief, 2016, 8: 93-97.","journal-title":"Data Brief"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"2","DOI":"10. 1016\/j. mehy. 2018. 12. 004","volume":"123","author":"Wang B","year":"2019","unstructured":"Wang B, Xu A. Aryl hydrocarbon receptor pathway participates in myocardial                         ischemia reperfusion injury by regulating mitochondrial apoptosis. Med                             Hypotheses, 2019, 123: 2-5.","journal-title":"Med                             Hypotheses"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"3195","DOI":"10. 1182\/blood-2012-08-453597","volume":"121","author":"Zhou Y","year":"2013","unstructured":"Zhou Y, Tung HY, Tsai YM, Hsu SC, Chang HW, Kawasaki H, Tseng HC. Aryl hydrocarbon receptor controls murine mast cell homeostasis. Blood, 2013, 121: 3195-3204.","journal-title":"Blood"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"174","DOI":"10. 3892\/mmr. 2017. 6580","volume":"16","author":"Zhou B","year":"2017","unstructured":"Zhou B, Wang X, Li F, Wang Y, Yang L, Zhen X, Tan W. Mitochondrial activity and oxidative stress functions are                         influenced by the activation of AhR-induced CYP1A1 overexpression in                         cardiomyocytes. Mol Med Rep, 2017, 16: 174-180.","journal-title":"Mol Med Rep"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"1312","DOI":"10. 1182\/bloodadvances. 2017008227","volume":"1","author":"Boddu P","year":"2017","unstructured":"Boddu P, Kantarjian HM, Garcia-Manero G, Ravandi F, Verstovsek S, Jabbour E, Borthakur G. Treated secondary acute myeloid leukemia: a distinct high-risk                         subset of AML with adverse prognosis. Blood                             Adv, 2017, 1: 1312-1323.","journal-title":"Blood                             Adv"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"7031","DOI":"10.3892\/ol.2017.7177","volume":"14","author":"Jia Y","year":"2017","unstructured":"Jia Y, Zhang C, Hua M, Wang M, Chen P, Ma D. Aberrant NLRP3 inflammasome associated with aryl hydrocarbon                         receptor potentially contributes to the imbalance of T\u2011helper cells in                         patients with acute myeloid leukemia. Oncol Lett, 2017, 14: 7031-7044.","journal-title":"Oncol Lett"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.coi.2020.12.003","volume":"70","author":"Leclerc D","year":"2021","unstructured":"Leclerc D, Staats Pires AC, Guillemin GJ, Gilot D. Detrimental activation of AhR pathway in cancer: an overview of                         therapeutic strategies. Curr Opin                             Immunol, 2021, 70: 15-26.","journal-title":"Curr Opin                             Immunol"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1182\/blood-2018-03-838474","volume":"132","author":"Scoville SD","year":"2018","unstructured":"Scoville SD, Nalin AP, Chen L, Chen L, Zhang MH, McConnell K, Beceiro Casas S. Human AML activates the aryl hydrocarbon receptor pathway to                         impair NK cell development and function. Blood, 2018, 132: 1792-1804.","journal-title":"Blood"},{"key":"CITATION37","doi-asserted-by":"crossref","unstructured":"Ly M, Rentas S, Vujovic A, Wong N, Moreira S, Xu J, Holzapfel N, et                         al. Diminished AHR signaling drives human acute myeloid leukemia                         stem cell maintenance.                              Cancer                         Res                          2019, 79: 5799\u20135811.","DOI":"10.1158\/0008-5472.CAN-19-0274"},{"key":"CITATION38","doi-asserted-by":"crossref","unstructured":"Ashton TM, McKenna WG, Kunz-Schughart LA, Higgins GS. Oxidative                         phosphorylation as an emerging target in cancer therapy.                              Clin                         Cancer Res                          2018, 24: 2482\u20132490.","DOI":"10.1158\/1078-0432.CCR-17-3070"},{"key":"CITATION39","doi-asserted-by":"crossref","unstructured":"Liu YM, Ge JY, Chen YF, Liu T, Chen L, Liu CC, Ma D, et                         al. Combined single-cell and spatial transcriptomics reveal the                         metabolic evolvement of breast cancer during early dissemination.                              Adv Sci (Weinh)                                                  2023, 10: e2205395.","DOI":"10.1002\/advs.202205395"},{"key":"CITATION40","doi-asserted-by":"crossref","unstructured":"Yucel B, Sonmez M. Repression of oxidative phosphorylation                         sensitizes leukemia cell lines to cytarabine.                                                       Hematology                          2018, 23: 330\u2013336.","DOI":"10.1080\/10245332.2017.1402454"},{"key":"CITATION41","doi-asserted-by":"publisher","first-page":"424","DOI":"10. 1182\/blood-2016-08-733196","volume":"129","author":"D\u00f6hner H","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, B\u00fcchner T, Dombret H. Diagnosis and management of AML in adults: 2017 ELN                         recommendations from an international expert panel. Blood, 2017, 129: 424-447.","journal-title":"Blood"},{"key":"CITATION42","doi-asserted-by":"publisher","first-page":"1249","DOI":"10. 1056\/NEJMoa0904544","volume":"361","author":"Fernandez HF","year":"2009","unstructured":"Fernandez HF, Sun Z, Yao X, Litzow MR, Luger SM, Paietta EM, Racevskis J. Anthracycline dose intensification in acute myeloid leukemia. N Engl J Med, 2009, 361: 1249-1259.","journal-title":"N Engl J Med"},{"key":"CITATION43","doi-asserted-by":"crossref","unstructured":"J\u00e4dersten M, Lilienthal I, Tsesmetzis N, Lourda M, Bengtz\u00e9n S,                         Bohlin A, Arnroth C, et al. Targeting SAMHD1 with                         hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute                         myeloid leukaemia: results from the HEAT-AML trial.                              J Intern Med                          2022, 292:                         925\u2013940.","DOI":"10.1111\/joim.13553"},{"key":"CITATION44","doi-asserted-by":"crossref","unstructured":"Farge T, Saland E, de Toni F, Aroua N, Hosseini M, Perry R, Bosc                         C, et al. Chemotherapy-resistant human acute myeloid                         leukemia cells are not enriched for leukemic stem cells but require                         oxidative metabolism.                              Cancer                         Discov                          2017, 7: 716\u2013735.","DOI":"10.1158\/2159-8290.CD-16-0441"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/4662EDD164904C81BAD0C0E6BC6FDC5E","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2024022","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/4662EDD164904C81BAD0C0E6BC6FDC5E","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T06:47:00Z","timestamp":1708930020000},"score":1,"resource":{"primary":{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2024022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":44,"URL":"https:\/\/doi.org\/10.3724\/abbs.2024022","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}